Disclosures for "Suspected Autoimmune Encephalitis in Hospitalized Adults: Diagnostic Yield and Predictors"
-
Dr. Hoshina has nothing to disclose.
-
Dr. Manzano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gilead Sciences. Dr. Manzano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for InfuCare Rx.
-
Dr. Mahler has received research support from The Sumaira Foundation.
-
Mr. Steuart has nothing to disclose.
-
Miss Leles Vieira de Souza has nothing to disclose.
-
Dr. Rajarajan has nothing to disclose.
-
Dr. Rodin has nothing to disclose.
-
Dr. Rettenmaier has nothing to disclose.
-
Dr. McEntire has nothing to disclose.
-
Dr. Mashlah has nothing to disclose.
-
Dr. Bilodeau has nothing to disclose.
-
Dr. Ali has nothing to disclose.
-
Dr. Wibecan has nothing to disclose.
-
Dr. Kerr has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for SK Lifesciences. Dr. Kerr has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven Pharmaceuticals. Dr. Kerr has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Kerr has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurelis. Dr. Kerr has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for QurAlis. Dr. Kerr has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven Pharmaceuticals. Dr. Kerr has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Epilepsia. The institution of Dr. Kerr has received research support from NINDS. The institution of Dr. Kerr has received research support from American Epilepsy Society. The institution of Dr. Kerr has received research support from American Academy of Neurology. The institution of Dr. Kerr has received research support from SK Life Science. The institution of Dr. Kerr has received research support from Biohaven Pharmaceuticals. Dr. Kerr has received publishing royalties from a publication relating to health care.
-
Dr. Linnoila has received personal compensation in the range of $10,000-$49,999 for serving as a expert respondent on autoimmune encephalitis with U.S. government/DHHS/Vaccine Injury Compensation Program.